Literature DB >> 27570073

mTORC2 Responds to Glutamine Catabolite Levels to Modulate the Hexosamine Biosynthesis Enzyme GFAT1.

Joseph G Moloughney1, Peter K Kim1, Nicole M Vega-Cotto1, Chang-Chih Wu1, Sisi Zhang2, Matthew Adlam1, Thomas Lynch1, Po-Chien Chou1, Joshua D Rabinowitz2, Guy Werlen1, Estela Jacinto3.   

Abstract

Highly proliferating cells are particularly dependent on glucose and glutamine for bioenergetics and macromolecule biosynthesis. The signals that respond to nutrient fluctuations to maintain metabolic homeostasis remain poorly understood. Here, we found that mTORC2 is activated by nutrient deprivation due to decreasing glutamine catabolites. We elucidate how mTORC2 modulates a glutamine-requiring biosynthetic pathway, the hexosamine biosynthesis pathway (HBP) via regulation of expression of glutamine:fructose-6-phosphate amidotransferase 1 (GFAT1), the rate-limiting enzyme of the HBP. GFAT1 expression is dependent on sufficient amounts of glutaminolysis catabolites particularly α-ketoglutarate, which are generated in an mTORC2-dependent manner. Additionally, mTORC2 is essential for proper expression and nuclear accumulation of the GFAT1 transcriptional regulator, Xbp1s. Thus, while mTORC1 senses amino acid abundance to promote anabolism, mTORC2 responds to declining glutamine catabolites in order to restore metabolic homeostasis. Our findings uncover the role of mTORC2 in metabolic reprogramming and have implications for understanding insulin resistance and tumorigenesis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27570073      PMCID: PMC5006067          DOI: 10.1016/j.molcel.2016.07.015

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  32 in total

1.  CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.

Authors:  Renaud Le Floch; Johanna Chiche; Ibtissam Marchiq; Tanesha Naiken; Tanesha Naïken; Karine Ilc; Karine Ilk; Clare M Murray; Susan E Critchlow; Danièle Roux; Marie-Pierre Simon; Jacques Pouysségur
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c.

Authors:  Asami Hagiwara; Marion Cornu; Nadine Cybulski; Pazit Polak; Charles Betz; Francesca Trapani; Luigi Terracciano; Markus H Heim; Markus A Rüegg; Michael N Hall
Journal:  Cell Metab       Date:  2012-04-19       Impact factor: 27.287

3.  Mammalian target of rapamycin complex 2 modulates αβTCR processing and surface expression during thymocyte development.

Authors:  Po-Chien Chou; Won Jun Oh; Chang-Chih Wu; Joseph Moloughney; Markus A Rüegg; Michael N Hall; Estela Jacinto; Guy Werlen
Journal:  J Immunol       Date:  2014-06-30       Impact factor: 5.422

Review 4.  Restraining PI3K: mTOR signalling goes back to the membrane.

Authors:  Laura S Harrington; Greg M Findlay; Richard F Lamb
Journal:  Trends Biochem Sci       Date:  2005-01       Impact factor: 13.807

5.  mTOR complex 2 regulates proper turnover of insulin receptor substrate-1 via the ubiquitin ligase subunit Fbw8.

Authors:  Sung Jin Kim; Michael A DeStefano; Won Jun Oh; Chang-chih Wu; Nicole M Vega-Cotto; Monica Finlan; Dou Liu; Bing Su; Estela Jacinto
Journal:  Mol Cell       Date:  2012-11-08       Impact factor: 17.970

Review 6.  Multiple amino acid sensing inputs to mTORC1.

Authors:  Mitsugu Shimobayashi; Michael N Hall
Journal:  Cell Res       Date:  2015-12-11       Impact factor: 25.617

Review 7.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.

Authors:  R J DeBerardinis; T Cheng
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

Review 8.  Roles of N-linked glycans in the endoplasmic reticulum.

Authors:  Ari Helenius; Markus Aebi
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

9.  mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc.

Authors:  Kenta Masui; Kazuhiro Tanaka; David Akhavan; Ivan Babic; Beatrice Gini; Tomoo Matsutani; Akio Iwanami; Feng Liu; Genaro R Villa; Yuchao Gu; Carl Campos; Shaojun Zhu; Huijun Yang; William H Yong; Timothy F Cloughesy; Ingo K Mellinghoff; Webster K Cavenee; Reuben J Shaw; Paul S Mischel
Journal:  Cell Metab       Date:  2013-10-17       Impact factor: 27.287

Review 10.  Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the Spot.

Authors:  Deborah C I Goberdhan; Clive Wilson; Adrian L Harris
Journal:  Cell Metab       Date:  2016-04-12       Impact factor: 27.287

View more
  42 in total

1.  mTOR/AMPK signaling in the brain: Cell metabolism, proteostasis and survival.

Authors:  Carla Garza-Lombó; Annika Schroder; Elsa M Reyes-Reyes; Rodrigo Franco
Journal:  Curr Opin Toxicol       Date:  2018-05-17

Review 2.  Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.

Authors:  Andréia Vasconcelos-Dos-Santos; Rafaela Muniz de Queiroz; Bruno da Costa Rodrigues; Adriane R Todeschini; Wagner B Dias
Journal:  J Bioenerg Biomembr       Date:  2018-01-11       Impact factor: 2.945

Review 3.  The Complex Roles of Mechanistic Target of Rapamycin in Adipocytes and Beyond.

Authors:  Peter L Lee; Su Myung Jung; David A Guertin
Journal:  Trends Endocrinol Metab       Date:  2017-02-22       Impact factor: 12.015

Review 4.  Glutamine Metabolism in Cancer: Understanding the Heterogeneity.

Authors:  Ahmad A Cluntun; Michael J Lukey; Richard A Cerione; Jason W Locasale
Journal:  Trends Cancer       Date:  2017-03

5.  Deduction and exploration of the evolution and function of vertebrate GFPT family.

Authors:  Si-Ang Wei; Ran Xu; Yu-Yao Ji; Zhi-Wen Ding; Yun-Zeng Zou
Journal:  Genes Genomics       Date:  2022-01-17       Impact factor: 1.839

6.  mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation.

Authors:  Joseph G Moloughney; Nicole M Vega-Cotto; Sharon Liu; Chadni Patel; Peter K Kim; Chang-Chih Wu; Danielle Albaciete; Cedric Magaway; Austin Chang; Swati Rajput; Xiaoyang Su; Guy Werlen; Estela Jacinto
Journal:  J Biol Chem       Date:  2018-09-10       Impact factor: 5.157

7.  Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis.

Authors:  Beatrice Tassone; Stefania Saoncella; Francesco Neri; Ugo Ala; Davide Brusa; Mark A Magnuson; Paolo Provero; Salvatore Oliviero; Chiara Riganti; Enzo Calautti
Journal:  Cell Death Differ       Date:  2017-02-17       Impact factor: 15.828

Review 8.  Targeting immune cell metabolism in kidney diseases.

Authors:  Paulo José Basso; Vinicius Andrade-Oliveira; Niels Olsen Saraiva Câmara
Journal:  Nat Rev Nephrol       Date:  2021-04-07       Impact factor: 28.314

Review 9.  The Role of Pi, Glutamine and the Essential Amino Acids in Modulating the Metabolism in Diabetes and Cancer.

Authors:  Lakshmipathi Vadlakonda; Meera Indracanti; Suresh K Kalangi; B Meher Gayatri; Navya G Naidu; Aramati B M Reddy
Journal:  J Diabetes Metab Disord       Date:  2020-08-19

Review 10.  MTOR Signaling and Metabolism in Early T Cell Development.

Authors:  Guy Werlen; Ritika Jain; Estela Jacinto
Journal:  Genes (Basel)       Date:  2021-05-13       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.